Evidence map›Paper›PMID 20686600›Full record

ArticlePloS one2010

Mutations of Francisella novicida that alter the mechanism of its phagocytosis by murine macrophages.

Xin-He Lai, Renee L Shirley, Lidia Crosa, Duangjit Kanistanon, Rebecca Tempel, Robert K Ernst, Larry A Gallagher, Colin Manoil, Fred Heffron

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Genetic Determinants of Antibiotic Resistance inFrontiers in microbiology · 2021
    Review
  3. Article
  4. Differential Growth ofFrontiers in microbiology · 2017
    Article
  5. Review
  6. Article
  7. Article
  8. From the Outside-In: The Francisella tularensis Envelope and Virulence.Frontiers in cellular and infection microbiology · 2015
    Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Mechanisms of Francisella tularensis intracellular pathogenesis.Cold Spring Harbor perspectives in medicine · 2013
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Xin-He LaiDepartment of Molecular Microbiology and Immunology, Oregon Health & Science University, Portland, Oregon, United States of America. laixinhe@gmail.com
Renee L Shirley
Lidia Crosa
Duangjit Kanistanon
Rebecca Tempel
Robert K Ernst
Larry A Gallagher
Colin Manoil
Fred Heffron
Oregon Health & Science University · USUniversity of Maryland, Baltimore · USUniversity of Washington · USVirogenomics BioDevelopment (United States) · US

Funding

Genetically Defined Attenuated Living Vaccine for FrancisellaR41AI072906 · NIAID · VIROGENOMICS, INC. · PI HEFFRON, FRED L · 2007 to 2008
$588k
NIAID NIH HHS R41 AI072906NIAID NIH HHS U54 AI05714
6 · The paper itself

Abstract

Infection with the bacterial pathogen Francisella tularensis tularensis (F. tularensis) causes tularemia, a serious and debilitating disease. Francisella tularensis novicida strain U112 (abbreviated F. novicida), which is closely related to F. tularensis, is pathogenic for mice but not for man, making it an ideal model system for tularemia. Intracellular pathogens like Francisella inhibit the innate immune response, thereby avoiding immune recognition and death of the infected cell. Because activation of inflammatory pathways may lead to cell death, we reasoned that we could identify bacterial genes involved in inhibiting inflammation by isolating mutants that killed infected cells faster than the wild-type parent. We screened a comprehensive transposon library of F. novicida for mutant strains that increased the rate of cell death following infection in J774 macrophage-like cells, as compared to wild-type F. novicida. Mutations in 28 genes were identified as being hypercytotoxic to both J774 and primary macrophages of which 12 were less virulent in a mouse infection model. Surprisingly, we found that F. novicida with mutations in four genes (lpcC, manB, manC and kdtA) were taken up by and killed macrophages at a much higher rate than the parent strain, even upon treatment with cytochalasin D (cytD), a classic inhibitor of macrophage phagocytosis. At least 10-fold more mutant bacteria were internalized by macrophages as compared to the parent strain if the bacteria were first fixed with formaldehyde, suggesting a surface structure is required for the high phagocytosis rate. However, bacteria were required to be viable for macrophage toxicity. The four mutant strains do not make a complete LPS but instead have an exposed lipid A. Interestingly, other mutations that result in an exposed LPS core were not taken up at increased frequency nor did they kill host cells more than the parent. These results suggest an alternative, more efficient macrophage uptake mechanism for Francisella that requires exposure of a specific bacterial surface structure(s) but results in increased cell death following internalization of live bacteria.

Indexed as

AnimalsCell LineCells, CulturedFemaleFrancisellaLipopolysaccharidesMacrophagesMiceMice, Inbred BALB CMutationPhagocytosisLipopolysaccharides

Identifiers

PMID20686600
PMCPMC2912274
OpenAlexW1977264228

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.